 NEW YORK, Nov. 04, 2020 GLOBE NEWSWIRE -- Intra-Cellular Therapies, Inc. Nasdaq:ITCI, a biopharmaceutical company focused on the development of and commercialization of therapeutics for central nervous system CNS disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Monday, November 9, 2020, to provide a corporate update and discuss details of the Companys financial results for the quarter ended September 30, 2020. 